Rani Therapeutics Holdings (RANI) Notes Payables (2020 - 2022)

Rani Therapeutics Holdings has reported Notes Payables for 3 years, with the latest figure at $53000.0 in Q4 2022.

• On a quarterly basis, Notes Payables fell 57.94% year-over-year to $53000.0 in Q4 2022; TTM through Dec 2022 was $53000.0, a 57.94% decrease from a year earlier, with the FY2022 full-year figure at $53000.0, down 57.94% from the prior year.
• Notes Payables was $53000.0 for Q4 2022 at Rani Therapeutics Holdings, down from $55000.0 in the prior quarter.
• The five-year high for Notes Payables was $883000.0 in Q2 2021, with the low at $30000.0 in Q2 2022.
• Average Notes Payables over 3 years is $215250.0, with a median of $133000.0 recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Notes Payables retreated 13.1% in 2021, then sank 96.6% in 2022.
• Over 3 years, Notes Payables stood at $145000.0 in 2020, then dropped by 13.1% to $126000.0 in 2021, then plunged by 57.94% to $53000.0 in 2022.
• The last three Notes Payables figures came in at $53000.0 (Q4 2022), $55000.0 (Q3 2022), and $30000.0 (Q2 2022), per Business Quant data.